Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313198701> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4313198701 endingPage "189" @default.
- W4313198701 startingPage "3" @default.
- W4313198701 abstract "Cancer cachexia is a progressive functional disorder that cannot be completely reversed with normal nutritional support. It is a multifactorial syndrome characterized by a persistent loss of skeletal muscle mass (with or without fat loss), and anamorelin is the only drug approved for the treatment of cancer cachexia in Japan." @default.
- W4313198701 created "2023-01-06" @default.
- W4313198701 creator A5016008286 @default.
- W4313198701 creator A5044704304 @default.
- W4313198701 creator A5048391695 @default.
- W4313198701 creator A5055434512 @default.
- W4313198701 creator A5078654346 @default.
- W4313198701 date "2022-01-01" @default.
- W4313198701 modified "2023-09-27" @default.
- W4313198701 title "Improvement of muscle weakness by nalfurafine hydrochloride (TRK-820), a kappa opioid receptor agonist" @default.
- W4313198701 doi "https://doi.org/10.1254/jpssuppl.96.0_3-b-p-189" @default.
- W4313198701 hasPublicationYear "2022" @default.
- W4313198701 type Work @default.
- W4313198701 citedByCount "0" @default.
- W4313198701 crossrefType "journal-article" @default.
- W4313198701 hasAuthorship W4313198701A5016008286 @default.
- W4313198701 hasAuthorship W4313198701A5044704304 @default.
- W4313198701 hasAuthorship W4313198701A5048391695 @default.
- W4313198701 hasAuthorship W4313198701A5055434512 @default.
- W4313198701 hasAuthorship W4313198701A5078654346 @default.
- W4313198701 hasBestOaLocation W43131987011 @default.
- W4313198701 hasConcept C121608353 @default.
- W4313198701 hasConcept C126322002 @default.
- W4313198701 hasConcept C134018914 @default.
- W4313198701 hasConcept C141071460 @default.
- W4313198701 hasConcept C170493617 @default.
- W4313198701 hasConcept C2776418732 @default.
- W4313198701 hasConcept C2777704314 @default.
- W4313198701 hasConcept C2778938600 @default.
- W4313198701 hasConcept C2779959927 @default.
- W4313198701 hasConcept C2780247198 @default.
- W4313198701 hasConcept C2992343062 @default.
- W4313198701 hasConcept C3020092424 @default.
- W4313198701 hasConcept C71924100 @default.
- W4313198701 hasConcept C98274493 @default.
- W4313198701 hasConceptScore W4313198701C121608353 @default.
- W4313198701 hasConceptScore W4313198701C126322002 @default.
- W4313198701 hasConceptScore W4313198701C134018914 @default.
- W4313198701 hasConceptScore W4313198701C141071460 @default.
- W4313198701 hasConceptScore W4313198701C170493617 @default.
- W4313198701 hasConceptScore W4313198701C2776418732 @default.
- W4313198701 hasConceptScore W4313198701C2777704314 @default.
- W4313198701 hasConceptScore W4313198701C2778938600 @default.
- W4313198701 hasConceptScore W4313198701C2779959927 @default.
- W4313198701 hasConceptScore W4313198701C2780247198 @default.
- W4313198701 hasConceptScore W4313198701C2992343062 @default.
- W4313198701 hasConceptScore W4313198701C3020092424 @default.
- W4313198701 hasConceptScore W4313198701C71924100 @default.
- W4313198701 hasConceptScore W4313198701C98274493 @default.
- W4313198701 hasIssue "0" @default.
- W4313198701 hasLocation W43131987011 @default.
- W4313198701 hasOpenAccess W4313198701 @default.
- W4313198701 hasPrimaryLocation W43131987011 @default.
- W4313198701 hasRelatedWork W189083227 @default.
- W4313198701 hasRelatedWork W1978882145 @default.
- W4313198701 hasRelatedWork W2079770713 @default.
- W4313198701 hasRelatedWork W2119527577 @default.
- W4313198701 hasRelatedWork W2137909139 @default.
- W4313198701 hasRelatedWork W2204868321 @default.
- W4313198701 hasRelatedWork W3113373009 @default.
- W4313198701 hasRelatedWork W3156034460 @default.
- W4313198701 hasRelatedWork W3178891317 @default.
- W4313198701 hasRelatedWork W2276872998 @default.
- W4313198701 hasVolume "96" @default.
- W4313198701 isParatext "false" @default.
- W4313198701 isRetracted "false" @default.
- W4313198701 workType "article" @default.